Pharma
Mass. girl, parents awarded $63M in Motrin lawsuit
February 13, 2013 4:04 pm | by The Associated Press | News | CommentsHealth care company Johnson & Johnson has been told to pay a Massachusetts teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago. A Plymouth Superior Court jury Wednesday...
Deprived Bacteria Unable to Resist Antibiotics
February 12, 2013 11:42 am | News | CommentsResearchers “cured” a strain of bacteria of its ability to resist an antibiotic in an experiment that has implications for a long-standing public health crisis.
Improved Tool Promotes Universal Health-Care Standards
February 12, 2013 11:31 am | News | CommentsResearchers have released an improved version of an online decision-support tool that has helped health-care providers adopt universal standards to identify materials, locations and partners within the U.S. health-care system.
Newly Identified Protein Blocks HIV, Other Viruses
February 12, 2013 11:23 am | News | CommentsA team of researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others.
Avatar Interaction Can Reduce Depression Symptoms
February 11, 2013 4:54 pm | News | CommentsYoung adults are often reluctant to seek treatment for mental health problems because of the stigma, inadequate insurance coverage and difficulty finding a mental health care provider, but a new study by suggests that depression symptoms may be significantly reduced when patients interact with computerized avatars— virtual 3D images of a healthcare provider like a nurse practitioner or physician— to rehearse office visits ahead of time and learn self-management skills.
Cell Circuits Remember Their History
February 11, 2013 1:35 pm | News | CommentsMIT engineers have created genetic circuits in bacterial cells that not only perform logic functions, but also remember the results, which are encoded in the cell’s DNA and passed on for dozens of generations. The circuits could be used as long-term environmental sensors, efficient controls for biomanufacturing, or to program stem cells to differentiate into other cell types.
A New Genre of “Intelligent” Micro- and Nanomotors
January 31, 2013 1:20 pm | News | CommentsEnzymes, workhorse molecules of life that underpin almost every biological process, may have a new role as “intelligent” micro- and nanomotors with applications in medicine, engineering and other fields.
New Tool for Mining Bacterial Genome for Novel Drugs
January 28, 2013 10:45 am | News | CommentsVanderbilt biochemists have discovered that the process bacteria undergo when they become drug resistant can act as a powerful tool for drug discovery. Their findings should give a major boost to natural products drug discovery by substantially increasing the number of novel compounds that scientists can extract from individual microorganisms.
Major Step Toward an Alzheimer’s Vaccine
January 16, 2013 10:13 am | News | CommentsA team of researchers has discovered a way to stimulate the brain’s natural defense mechanisms in people with Alzheimer’s disease. This breakthrough opens the door to the development of a treatment for Alzheimer’s disease and a vaccine to prevent the illness.
Advancing Oncology Research: Novel Assays for Epigenetics Drug Discovery
January 7, 2013 11:38 am | by David Titus, PhD and Eric Morreale PhD, Life Sciences and Technology, PerkinElmer | Articles | CommentsEpigenetics research has expanded rapidly over the last several years, as evidenced by the exponential increase in published literature in this field. Breakthroughs have been made in the elucidation of basic epigenetic mechanisms such as histone modification, and with these advances have come an understanding of the critical role epigenetic modifications play in the development and progression of cancer.
New Method for Uncovering Side Effects Before a Drug Hits the Market
January 3, 2013 11:16 am | News | CommentsSide effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientists are now reporting the development of a new way to predict those adverse reactions ahead of time. The method could save patients from severe side effects and save drug companies time and money.
Merck KGaA Completes Millipore Acquisition
August 12, 2010 8:54 am | by Edited for tone and content by Lily Barback | Articles | CommentsMerck KGaA announced the successful completion of its acquisition of Millipore. The closing follows the approval of the acquisition by Millipore’s shareholders and the satisfaction of other customary conditions, including antitrust clearance in the United States and Europe
Caliper Awarded Additional Task Order
August 4, 2010 11:44 am | by Edited for tone and content by Lily Barback | Articles | CommentsCaliper Life Sciences, Inc. announced that its Caliper Discovery Alliances and Services unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency (EPA) for the EPA’s ToxCast screening program
AVI BioPharma Awarded up to $291 Million U.S. Government Contract
August 4, 2010 10:42 am | by Edited for tone and content by Lily Barback | Articles | CommentsAVI BioPharma, Inc. announced that it has been awarded a new contract for up to approximately $291 million total with the U.S. Department of Defense Chemical and Biological Defense Program through the U.S. Army Space and Missile Defense Command for the development of the Company's hemorrhagic fever virus therapeutic candidates, AVI-6002 and AVI-6003, for Ebola and Marburg viruses, respectively.
Asuragen and Life Technologies Launch Leukemia Test
August 4, 2010 10:25 am | by Edited for tone and content by Lily Barback | Articles | CommentsAsuragen, Inc. and Life Technologies Corporation announced that they have completed CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML)
A Flash of Inspiration
October 13, 2009 11:02 am | Blogs | CommentsAccording to IBM, DNA origami causes single DNA molecules to self assemble in solution via a reaction between a long single strand of viral DNA and a mixture of different short synthetic oligonucleotide strands.
They Like Me, They Like Me Not
October 13, 2009 10:52 am | Blogs | CommentsIt should come as no surprise to you all that your profession—science—is highly respected by the general public. I’m sure many of you expected this, but now there is validation in the form of a survey conducted by The Pew Research Center for the People and the Press.
Why We Do What We Do
October 13, 2009 10:50 am | Blogs | CommentsOur industry is unique in that it is often only limited by the imagination of those working in it. If you can think of it and find funding (which often presents its own difficulties), then you can work on it.
Centrifuge Centerpieces
July 21, 2009 12:07 pm | Product Releases | CommentsNewly designed centerpieces used in the Beckman Coulter XL-A and XL-I instruments allow the systems to provide precise, repeatable measurement of pharmaceutical sample aggregation in pharmaceutical research and formulation laboratories.
MALDI TOF Mass Spectrometer
June 15, 2009 8:43 am | Product Releases | CommentsShimadzu Scientific Instruments introduces the AXIMA Resonance MALDI QIT TOF mass spectrometer for the structural characterization and sequencing of biomolecules.
High Definition Mass Spectrometer
June 15, 2009 8:43 am | Product Releases | CommentsThe Waters SYNAPT G2 System features new QuanTof and enhanced High Definition MS technologies intended to accelerate scientists toward their research goals.
Columns for Protein Separations
May 28, 2009 8:25 am | Product Releases | CommentsPall Life Sciences has expanded its line of AcroSep chromatography columns (1 mL) to provide lab technicians with a full palette of color-coded columns that address the wide-range of chromatography separation requirements.
UPLC Solution for Glycan Characterization
May 28, 2009 8:25 am | Product Releases | CommentsWaters introduced the first UltraPerformance LC (UPLC) analytical solution for the characterization of 2-AB labeled glycans from glycoproteins.
Isoelectric Focusing
May 13, 2009 10:47 am | Product Releases | CommentsBeckman Coulter introduces advanced isoelectric focusing (IEF) technology, featuring a new peptide-based pI Marker Kit for the charge heterogeneity analysis of biotherapeutics.
Capillary Electrophoresis Platform
April 16, 2009 1:33 pm | Product Releases | CommentsBeckman Coulter introduces the PA 800 plus Pharmaceutical Analysis System, a next-generation capillary electrophoresis (CE) platform designed in collaboration with biopharmaceutical development and QC groups.
